Taro Pharmaceutical Industries Ltd. Provides Preliminary 2011 Full Year and Q4 Results
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” or the “Company,” Pink Sheets: TAROF) today provided unaudited financial results for the quarter and full year ended December 31, 2011.
Fourth Quarter 2011 Highlights vs. 2010
Net sales of $148.1 million, increased $45.5 million, or 44.3%
Fourth Quarter 2011 Highlights vs. 2010
Net sales of $148.1 million, increased $45.5 million, or 44.3%